JPRN-C000000098未知未知
Gemcitabine / Docetaxel combination chemotherapy for non-small cell lung cancer patient of safety confirmation test research - Safety test on GEM/DOC combination chemotherapy to NSCLC
agano Prefecture lung cancer chemotherapy Study Group0 个研究点目标入组 200 人开始时间: 2010年12月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.It a large amount is pericardial fluid with the subjective symptom is does pleural effusion or is a patient who admits as for the peritoneal fluid. 2.Patient with bone metastasis and brain metastasis focus where vena cava superior syndrome and pain are strong to need radiotherapy in emergency 3.It is a patient from whom the having infectious disease is doubted as for the patient and generation of heat that has the infectious disease. 4.It is a patient who has as for the syndrome of complication. 5.Patient who has clear tip neurological symptom (However, the one that originates in an original disease is excluded). 6.Patient who has the past of clear medicine hypersensitivity to treatment 7.Case from whom interstitial pneumonia or fibroid lung clear because of simple X rays of chest is admitted 8.Patient who has pregnant woman or possibility of pregnancy Case who judged that physician in charge is improper to this treatment object
研究者
相似试验
招募中
2 期
Chemotherapy using gemcitabine and docetaxel for advanced bone and soft tissue sarcomaadvanced bone and soft tissue tumorJPRN-UMIN000021202agoya City University, Graduate School of Medical Science10
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Biological Targeted TreatmentSUCCESS B-Trial - SUCCESS-BPatientinnen mit primärem epithelialem invasivem MammakarzinomEUCTR2007-001094-29-DEKlinikum der LM
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Extended Bisphosphonate and Surveillance-Trial SUCCESS-Trial - SUCCESSThis is an open-label, multicenter, 2x2 factorial design, randomized controlled, Phase III study comparing the time to recurrence after randomisation in patients with early primary breast cancer.EUCTR2005-000490-21-DE1. Frauenklinik der LMU- Innenstadt
已完成
不适用
eoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancerbladder cancerJPRN-UMIN000003146Department of Urology, Graduate School of Biomedical Sciences Hiroshima University30
进行中（未招募）
1 期
A fase I/II trial with docetaxel and gemcitabine in hormone refractory prostate cancerHormone fractory prostate cancerEUCTR2004-002353-31-DKOrganisation name was not entered60